EIF2AK3: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 24: | Line 24: | ||
[[Category:Medical genetics]] | [[Category:Medical genetics]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 10:24, 17 March 2025
EIF2AK3 (Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3) is a protein that in humans is encoded by the EIF2AK3 gene. This protein is part of the PERK pathway, which plays a crucial role in the Unfolded Protein Response (UPR). The UPR is activated in response to an accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER).
Function[edit]
EIF2AK3 is an enzyme that acts as a protein kinase. It phosphorylates the alpha subunit of eukaryotic translation-initiation factor 2 (EIF2), leading to its inactivation and thus to a rapid reduction of translational initiation and repression of global protein synthesis. This is a necessary step in triggering the unfolded protein response (UPR).
Clinical significance[edit]
Mutations in the EIF2AK3 gene are associated with Wolcott-Rallison Syndrome, a rare autosomal recessive disorder characterized by early-onset diabetes mellitus, epiphyseal dysplasia, and other variable clinical manifestations.
See also[edit]
References[edit]
<references />
